Lifecore Biomedical (NASDAQ:LFCR) and Acreage (OTCMKTS:ACRGF) Financial Comparison

Acreage (OTCMKTS:ACRGF) and Lifecore Biomedical (NASDAQ:LFCR) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations and risk.

Insider & Institutional Ownership

83.4% of Lifecore Biomedical shares are owned by institutional investors. 32.7% of Lifecore Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Acreage and Lifecore Biomedical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acreage	N/A	N/A	N/A
Lifecore Biomedical	-29.93%	N/A	-16.16%

Earnings & Valuation

This table compares Acreage and Lifecore Biomedical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acreage	N/A	N/A	N/A	N/A	N/A
Lifecore Biomedical	$128.87 million	1.33	-$40.50 million	($1.07)	-4.24

Acreage has higher earnings, but lower revenue than Lifecore Biomedical.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Acreage and Lifecore Biomedical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acreage	0	0	0	0	0.00
Lifecore Biomedical	1	2	1	0	2.00

Lifecore Biomedical has a consensus price target of $6.50, indicating a potential upside of 43.17%. Given Lifecore Biomedical’s stronger consensus rating and higher possible upside, analysts plainly believe Lifecore Biomedical is more favorable than Acreage.

Summary

Lifecore Biomedical beats Acreage on 6 of the 8 factors compared between the two stocks.

About Acreage

Acreage Holdings, Inc. engages in owning and operating cannabis licenses and assets in the U.S. with respect to the number of states with cannabis related licenses. It focuses on the cultivation, processing, and distribution operations. The company was founded by Kevin P. Murphy on July 12, 1989 and is headquartered in New York, NY.

About Lifecore Biomedical

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.